SUGAR CHAIN MARKER AS MEASURE OF DISEASE CONDITIONS OF HEPATIC DISEASES

The present invention is directed to developing a glycan markers capable of detecting a hepatic disease, and more specifically to developing a glycan marker indicating a hepatic disease-state. Furthermore, the present invention is also directed to developing a glycan marker capable of distinguishing...

Full description

Saved in:
Bibliographic Details
Main Authors ANGATA, TAKASHI, TOGAYACHI, AKIRA, SHIKANAI, TOSHIHIDE, SOGABE, MAKI, MIZOKAMI MASASHI, NARIMATSU, HISASHI, OHKURA, TAKASHI, TANAKA YASUHITO, KAJI, HIROYUKI, KUNO, ATSUSHI, OCHOU, MAKOTO, IKEHARA, YUZURU, HIRABAYASHI, JUN
Format Patent
LanguageEnglish
French
German
Published 23.05.2012
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to developing a glycan markers capable of detecting a hepatic disease, and more specifically to developing a glycan marker indicating a hepatic disease-state. Furthermore, the present invention is also directed to developing a glycan marker capable of distinguishing hepatic disease-states with the progress of hepatocarcinoma. The present inventors identified, among the serum glycoproteins, glycopeptides and glycoproteins in which a glycan structure specifically changes due to a hepatic diseases including hepatocarcinoma and provide these as novel glycan markers (glycopeptide and glycoprotein) specific to hepatic disease-states.
Bibliography:Application Number: EP20100799822